ReviewMolecular therapy. Methods & clinical development2021

CRISPR-Cas9 to induce fetal hemoglobin for the treatment of sickle cell disease.

Selami Demirci et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.